You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠集團(000513.SZ)附屬新冠抗原檢測試劑國內獲批上市
格隆匯 04-13 17:45

格隆匯4月13日丨麗珠集團(000513.SZ)公佈,公司控股附屬公司珠海麗珠試劑股份有限公司(簡稱“麗珠試劑”)自主研發的新型冠狀病毒(2019-nCoV)抗原檢測試劑盒(乳膠法)獲國家藥品監督管理局批准註冊上市。

公司上述新型冠狀病毒(2019-nCoV)抗原檢測試劑盒(乳膠法)適用於鼻咽拭子、口咽拭子、鼻拭子三種樣本類型,檢測時間15分鐘,操作簡單、結果清晰、易於判讀,可用於自測。

公司該產品在國內獲批上市,豐富了公司產品線,提高了公司在相關領域的核心競爭力,對公司未來的經營發展將產生正面影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account